XERIS PHARMACEUTICALS INC Long-Term Debt, Maturity, Year Four
XERIS PHARMACEUTICALS INC had Long-Term Debt, Maturity, Year Four of $13.30 million as of 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour · last filed 2020-05-07
- 2020-03-31: Long-Term Debt, Maturity, Year Four $13.30M.
- 2019-12-31: Long-Term Debt, Maturity, Year Four $26.70M.
- 2019-09-30: Long-Term Debt, Maturity, Year Four $26.70M.
- 2019-06-30: Long-Term Debt, Maturity, Year Four $12.00M.
| Period end | Long-Term Debt, Maturity, Year Four |
|---|---|
| 2020-03-31 | $13.30M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $26.70M 10-K · filed 2020-03-12 |
| 2019-09-30 | $26.70M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $12.00M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $12.00M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $12.00M 10-K · filed 2019-03-06 |
| 2018-09-30 | $12.00M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $6.72M 10-Q · filed 2018-08-14 |